Recombinant Human PLA2G1B Protein, CF

R&D Systems | Catalog # 5018-PL

R&D Systems
Loading...

Key Product Details

  • R&D Systems NS0-derived Recombinant Human PLA2G1B Protein (5018-PL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human PLA2G1B protein
Ala23-Ser148, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ala23

Predicted Molecular Mass

15 kDa

SDS-PAGE

18 kDa, reducing conditions

Activity

Measured by its ability to hydrolyze 1-Hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphoglycerol.
The specific activity is >2,500 pmol/min/µg, as measured under the described conditions.

Formulation, Preparation, and Storage

5018-PL
Formulation Supplied as a 0.2 μm filtered solution in Sodium Acetate and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: PLA2G1B

Secretory Phopholipase A2 is an enzyme that hydrolyses the sn-2 ester bond of phospholipids and cell membranes, generating non-esterified free fatty acids and lysophospholipids (1‑3). Most secretory PLA2s are stored in cytoplasmic granules and are released in the extracellular environment on appropriate cell activation. Thus, they are present at higher concentration in the plasma and biological fluids of patients with systemic inflammatory, autoimmune, or allergic disease, such as acute pancreatitis, rheumatoid arthritis, bronchial asthma, and allergic rhinitis. PLA2G1B has been thought to play major role in digestion of glycerophospholipids in nutrients, given its abundance in digestive organs (4). Since its expression has been observed in non-digestive organs including the lung, spleen, kidney, ovary, retina, brain, and neurons, its function may not limited to digestive role (5, 6). rhPLA2G1B has been maturated by cleaving the pro-peptide with trypsin, and the mature active form was further purified with ion-exchange column chromatograpy.

References

  1. Webb, N. R. (2005) Cur. Opin. Lipid. 16:341.
  2. Triggiani, M. et al. (2005) J. Allergy Clin. Immunol. 116:1000.
  3. Murakami, M. and Kudo, I. (2004) Biol. Pharm. Bull. 27:1158.
  4. de Haas, G. H. et al. (1968) Biochime. Biophysic. Acta. 159:118.
  5. Kolko, M. et al. (2005) Cell. Mol. Neurobiol. 25:1107.
  6. Kolko, M. et al. (2007) Acta Ophthalmol. Scand. 85:317.

Long Name

Phospholipase A2 Group IB

Alternate Names

PLA2, PLA2A, PPLA2

Entrez Gene IDs

5319 (Human); 18778 (Mouse); 29526 (Rat)

Gene Symbol

PLA2G1B

UniProt

Additional PLA2G1B Products

Product Documents for Recombinant Human PLA2G1B Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human PLA2G1B Protein, CF

For research use only

Customer Reviews for Recombinant Human PLA2G1B Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human PLA2G1B Protein, CF and earn rewards!

Have you used Recombinant Human PLA2G1B Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human PLA2G1B Protein, CF (5018-PL):

Materials
  • Assay Buffer: 50 mM HEPES, 1 mg/mL BSA, pH 7.0.
  • Substrate Buffer: 50 mM HEPES, 20 mM CaCl2, 1 mg/mL BSA, pH 7.0.
  • Recombinant Human Phospholipase A2 Group IB/PLA2G1B (rhPLA2G1B) (Catalog # 5018-PL)
  • Substrate: 1-hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphoglycerol Ammonium Salt, 2 mM stock in DMSO
  • Black 96-well Plate
  • Fluorescent Plate Reader
  1. Thaw Substrate at 37 °C for five minutes. Mix well.
  2. Dilute rhPLA2G1B to 0.02 ng/µL in Assay Buffer.
  3. Dilute Substrate to 100 µM in Substrate Buffer.
  4. Load into plate, 50 µL of 0.02 ng/µL rhPLA2G1B, and start reaction by adding 50 µL of 100 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of Substrate.
  5. Read at excitation and emission wavelengths of 345 nm and 395 nm (top read), respectively in kinetic mode for 5 minutes.  Shake the plate for 3 seconds between each read.
  6. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 1-pyrenedecanoic acid.

Per Well:
  • rhPLA2G1B: 0.001 µg
  • Substrate: 50 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes